| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/26/2011 | CN101543476B A naringin solid dispersion and the preparation method, and the application thereof |
| 01/26/2011 | CN101492672B Sulpho-oligodeoxynucleotide with immune stimulation activity and uses thereof |
| 01/26/2011 | CN101486716B Preparation of rifampin |
| 01/26/2011 | CN101474165B Polynucleotide microcapsule for treating diseases of livestock and poultry and preparation method thereof |
| 01/26/2011 | CN101461940B Photobacterium damsela vaccine as well as preparation method and use thereof |
| 01/26/2011 | CN101450094B Medicine for treating herpes zoster |
| 01/26/2011 | CN101445789B Application of dominant negative mutant F427N as anthrax toxin inhibitor and vaccine |
| 01/26/2011 | CN101444578B A traditional Chinese medicine for the treatment of hepatitis |
| 01/26/2011 | CN101417116B Decoction for treating urgent hepatitis with jaundice |
| 01/26/2011 | CN101361971B Preparation technique of Vibrio vulnificus whole-cell immunity stimulated compound vaccine and use thereof in aquatic animal |
| 01/26/2011 | CN101361898B Chinese herbal medicine gargle for preventing and treating AIDS stomatitis |
| 01/26/2011 | CN101348799B Construction method and pharmaceutical use of microRNA adenovirus expression plasmid for severe hepatitis related gene hfg12, hFas and hTNFR1 |
| 01/26/2011 | CN101347416B Capsules type acetaminopher drop and method of preparing the same |
| 01/26/2011 | CN101340902B Materials and methods for treating viral infections with a cysteamine compound |
| 01/26/2011 | CN101337971B Method for synthesizing antibiotic cefepime hydrochloride |
| 01/26/2011 | CN101336975B Traditional Chinese medicine ointment for treating dermatophytosis |
| 01/26/2011 | CN101297821B Phellinus linteus mycelia active glucoprotein and use thereof and preparation |
| 01/26/2011 | CN101293886B Preparing method and application of white banksia rose endogenetic epiphyte product of snail optical black shell bacterium ketone A |
| 01/26/2011 | CN101270101B Method for preparing potassium sodium dehydroandroan drographolide succinate for injection and its freeze-dried injection |
| 01/26/2011 | CN101265457B Vaccine for differentiating porcine actinobacillus pleuropneumonia serum 7-type double-gene deletion mutant of vaccine immunity and virus infection animal and application thereof |
| 01/26/2011 | CN101259082B Root canal anti-inflammation developing agent and preparation thereof |
| 01/26/2011 | CN101199726B Medicament for detoxifcation |
| 01/26/2011 | CN101095950B Hydrophobia vaccine freezing drying preparations for stable human beings and the preparations thereof |
| 01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
| 01/26/2011 | CN101045063B Clarithromycin water soluble preparation for injection use |
| 01/26/2011 | CN101023976B Medicine composition with anti-virus function |
| 01/26/2011 | CN101002849B Traditional Chinese medicine extractive or tablet for treating hepatitis, and its preparing method |
| 01/26/2011 | CN101002827B Micro-emulsion of mint oil with slow-releasing property, and its preparing method |
| 01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/25/2011 | US7875709 Nucleic acids encoding interleukin-18 mutants |
| 01/25/2011 | US7875592 Sulfated oligosaccharide derivatives |
| 01/25/2011 | US7875450 Virus-like particles for the induction of autoantibodies |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | CA2535370C Isothiazoloquinolones and related compounds as anti-infective agents |
| 01/25/2011 | CA2525499C Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 01/25/2011 | CA2476983C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
| 01/25/2011 | CA2457856C Sulphonated meso-tetraphenyl chlorins and their use as therapeutic agents |
| 01/25/2011 | CA2447765C 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/25/2011 | CA2337857C Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl) sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate |
| 01/25/2011 | CA2317455C Hydroxamic and carboxylic acid derivatives |
| 01/25/2011 | CA2281858C A method for making infectious, propagation defective tr339 virus particles and helper cells therefor |
| 01/25/2011 | CA2224309C Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 01/20/2011 | WO2011009039A2 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 01/20/2011 | WO2011008956A2 Mammalian genes involved in infection |
| 01/20/2011 | WO2011008947A2 Treatment and diagnosis of immune disorders |
| 01/20/2011 | WO2011008863A2 Stereoisomer peptides and their polymer conjugates for hiv disease |
| 01/20/2011 | WO2011008230A2 Rapamycin derivatives and ethers of n-propanolamines and uses related to infection |
| 01/20/2011 | WO2011008193A1 Fusidic acid dosing regimens for treatment of bacterial infections |
| 01/20/2011 | WO2011008110A1 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| 01/20/2011 | WO2011008087A1 Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit |
| 01/20/2011 | WO2011008086A1 Mixture of non-digestible oligosaccharides for stimulating the immune system |
| 01/20/2011 | WO2011007961A2 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitpoes |
| 01/20/2011 | WO2011007794A1 Zeolite and sericite-containing composition for medical or medical assisting uses |
| 01/20/2011 | WO2011007551A1 Sugar alcohol-containing antibacterial agent for inhibiting proliferation of periodontal disease-causing bacteria |
| 01/20/2011 | WO2011006536A1 Pyridyl-substituted isoquinoline derivatives with activity againstmycobacteriaand especially myobacterium tuberculosis |
| 01/20/2011 | WO2011006237A1 2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals |
| 01/20/2011 | WO2011006208A1 Anti -influenza agents |
| 01/20/2011 | WO2010134827A9 Extended acting oxygen generating composition for treating microbial infections |
| 01/20/2011 | WO2010132839A3 Aminoglycoside dosing regimens |
| 01/20/2011 | WO2010132777A3 Treatment of urinary tract infections with antibacterial aminoglycoside compounds |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015376 Papilloma Virus-Like Particles, Fusion Proteins as Well as Processes for Their Production |
| 01/20/2011 | US20110015264 Intramuscular antiviral treatments |
| 01/20/2011 | US20110015255 Treatment of an infection by an rna virus due to an rna dependent rna polymerase |
| 01/20/2011 | US20110015251 RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/20/2011 | US20110015231 Isoxazole and isothiazole compounds useful in the treatment of inflammation |
| 01/20/2011 | US20110015216 Solid Pharmaceutical Dosage Form |
| 01/20/2011 | US20110015203 Viral Polymerase Inhibitors |
| 01/20/2011 | US20110015196 Lupeol-type triterpene derivatives as antivirals |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |
| 01/20/2011 | US20110015188 Treatment of Seasonal Conditions |
| 01/20/2011 | US20110015184 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 01/20/2011 | US20110015180 Chemokine receptor antagonists |
| 01/20/2011 | US20110015174 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 01/20/2011 | US20110015165 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 01/20/2011 | US20110015149 Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
| 01/20/2011 | US20110015148 Antiviral nucleosides |
| 01/20/2011 | US20110015147 Anti-viral pyrimidine nucleoside analogues |
| 01/20/2011 | US20110015146 Nucleoside phosphoramidates |
| 01/20/2011 | US20110015137 Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activity |
| 01/20/2011 | US20110015122 Hepatitis b virus-binding polypeptides and methods of use thereof |
| 01/20/2011 | US20110015121 Cyclic compound and salt thereof |
| 01/20/2011 | US20110015120 Pharmaceutical and cosmetic compositions including lactoferrin, ciclopirox, etidronic acid |
| 01/20/2011 | US20110015119 Novel semi-synthetic glycopeptides as antibacterial agents |
| 01/20/2011 | US20110015118 C-Terminal Ifapsoriasin Fragments as Antimicrobial Peptides, the Production Thereof and Use Thereof |
| 01/20/2011 | US20110014276 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| 01/20/2011 | US20110014274 Vaccine composition containing synthetic adjuvant |
| 01/20/2011 | US20110014273 Method of Treating BCC |
| 01/20/2011 | US20110014272 Method for adjuvanting lipopolysaccharide (LPS) of Gram-negative bacteria |
| 01/20/2011 | US20110014271 Substituted Aniline Derivatives |
| 01/20/2011 | US20110014258 Gradient coating for biomedical applications |
| 01/20/2011 | US20110014242 Promoters for expression in modified vaccinia virus ankara |
| 01/20/2011 | US20110014237 Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets |
| 01/20/2011 | US20110014235 Therapeutic and vaccine polyelectrolyte nanoparticle compositions |
| 01/20/2011 | US20110014234 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 01/20/2011 | US20110014233 Psoralen-inactivated viral vaccine and method of preparation |
| 01/20/2011 | US20110014230 preparation of influenza virus vaccine antigens |
| 01/20/2011 | US20110014229 Chimeric flavivirus vectors |